CMPX Reports $209M Cash, Launches Tovecimig PFS/OS Data in April, Expands CTX-8371 Cohorts, FDA Clears CTX-10726 IND, Promotes Gong to CSO
Compass Therapeutics, Inc. Common Stock · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $2.22
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS